1. Home
  2. DNTH vs AMSC Comparison

DNTH vs AMSC Comparison

Compare DNTH & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • AMSC
  • Stock Information
  • Founded
  • DNTH 2015
  • AMSC 1987
  • Country
  • DNTH United States
  • AMSC United States
  • Employees
  • DNTH N/A
  • AMSC N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • AMSC Metal Fabrications
  • Sector
  • DNTH Health Care
  • AMSC Consumer Discretionary
  • Exchange
  • DNTH Nasdaq
  • AMSC Nasdaq
  • Market Cap
  • DNTH 565.7M
  • AMSC 616.8M
  • IPO Year
  • DNTH N/A
  • AMSC 1991
  • Fundamental
  • Price
  • DNTH $19.50
  • AMSC $18.41
  • Analyst Decision
  • DNTH Strong Buy
  • AMSC Strong Buy
  • Analyst Count
  • DNTH 8
  • AMSC 3
  • Target Price
  • DNTH $54.33
  • AMSC $33.67
  • AVG Volume (30 Days)
  • DNTH 418.5K
  • AMSC 626.5K
  • Earning Date
  • DNTH 05-08-2025
  • AMSC 05-28-2025
  • Dividend Yield
  • DNTH N/A
  • AMSC N/A
  • EPS Growth
  • DNTH N/A
  • AMSC N/A
  • EPS
  • DNTH N/A
  • AMSC 0.09
  • Revenue
  • DNTH $6,235,000.00
  • AMSC $198,191,000.00
  • Revenue This Year
  • DNTH N/A
  • AMSC $51.58
  • Revenue Next Year
  • DNTH N/A
  • AMSC $16.67
  • P/E Ratio
  • DNTH N/A
  • AMSC $203.16
  • Revenue Growth
  • DNTH 120.63
  • AMSC 46.42
  • 52 Week Low
  • DNTH $13.37
  • AMSC $11.36
  • 52 Week High
  • DNTH $32.27
  • AMSC $38.02
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 53.31
  • AMSC 46.79
  • Support Level
  • DNTH $18.37
  • AMSC $17.58
  • Resistance Level
  • DNTH $19.76
  • AMSC $18.78
  • Average True Range (ATR)
  • DNTH 1.93
  • AMSC 1.55
  • MACD
  • DNTH 0.45
  • AMSC 0.31
  • Stochastic Oscillator
  • DNTH 95.93
  • AMSC 82.65

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet world's demand for smarter, cleaner and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

Share on Social Networks: